Zoryl MV 2

Zoryl MV 2 is an Intas triple-combination tablet for type 2 diabetes containing glimepiride (a sulfonylurea), metformin (a biguanide), and voglibose (an alpha-glucosidase inhibitor), with a stronger glimepiride dose for tighter control.

• Type 2 diabetes when sugar stays high on lower doses
• Reducing post-meal glucose spikes
• Combined action on insulin output, sensitivity, and carb absorption

Glimepiride nudges the pancreas to release more insulin, metformin lowers sugar production by the liver and improves muscle uptake, and voglibose slows the gut breakdown of complex carbs so sugar rises more slowly after meals.

Take as prescribed by your doctor, with the first bite of a meal. Keep meals regular so blood sugar does not dip too low.

• Low blood sugar, especially with missed meals
• Bloating, gas, or loose stools
• Mild abdominal discomfort
• Possible vitamin B12 deficiency on long use

Tell your doctor about kidney, liver, or gut issues before starting. Carry plain glucose to manage lows, since voglibose slows down digestion of table sugar.

Store below 25 degrees Celsius in a dry place, away from light and moisture. Keep out of reach of children.